The Conversation (0)
Q BioMed 'looking for a significant return for shareholders' – CEO Denis Corin
Jun. 09, 2017 02:43PM PST
Biotech Investing
Denis Corin, chief executive of Q BioMed Inc. (OTCQB:QBIO) ) tells Proactive’s Andrew Scott their objective is to find innovative, under-valued and under-appreciated biotech assets out in the pharma world and bring them in-house through licensing and option agreements. ”[We’re] agnostic in terms of exit …. as long as there’s a significant return for shareholders”, …
Denis Corin, chief executive of Q BioMed Inc. (OTCQB:QBIO) ) tells Proactive’s Andrew Scott their objective is to find innovative, under-valued and under-appreciated biotech assets out in the pharma world and bring them in-house through licensing and option agreements.
”[We’re] agnostic in terms of exit …. as long as there’s a significant return for shareholders”, Corin says.
Source: www.proactiveinvestors.com